Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",1814,185,1.72 [1.44-2.07],3.9074651903816705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1829,185,3.28 [2.21-4.87],3.539137290224895e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,1853,187,2.84 [2.07-3.90],1.3175177268515978e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,1561,149,3.09 [2.11-4.51],5.687382105953471e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,1849,189,2.52 [2.02-3.14],1.7927045157370882e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,1855,187,2.34 [1.86-2.95],3.527258851781341e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,1841,187,2.58 [1.95-3.41],4.11648205788589e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,1849,189,2.47 [1.80-3.41],2.7188123362450174e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,1781,184,1.89 [1.53-2.33],2.163197226178246e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,1858,187,2.50 [1.80-3.48],5.788372194411058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,1869,190,2.14 [1.62-2.81],6.146627496515005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1855,187,2.50 [1.82-3.43],1.4530533193060997e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,1831,185,1.98 [1.58-2.49],3.099546092232487e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,1855,187,2.71 [1.94-3.78],5.170080997875317e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,1834,185,2.08 [1.68-2.58],1.3356076666789282e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1867,190,2.24 [1.79-2.80],2.2326183686128188e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,1854,188,2.77 [1.98-3.87],3.0260133841798542e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,1829,185,3.53 [2.61-4.78],3.2195345494492647e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,1787,181,2.72 [2.11-3.51],1.154962480232553e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,1869,190,2.93 [2.03-4.24],1.1882638160355228e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",1869,190,1.69 [1.42-2.03],7.968831864787425e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,1850,189,2.99 [2.16-4.13],4.55401497972102e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,1581,150,1.69 [1.41-2.03],1.9258009180024428e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,1869,190,2.14 [1.80-2.54],4.24884763530034e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,1862,190,2.97 [2.08-4.25],2.491545463965382e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,1814,185,1.68 [1.40-2.00],1.1835926340599865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,1864,189,1.67 [1.44-1.93],5.136437664467865e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1840,187,2.79 [1.97-3.96],8.543608472081856e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,1829,185,1.82 [1.49-2.23],8.459378333133776e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,1854,188,3.87 [2.49-6.02],1.7431723628387795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,1863,188,2.72 [1.89-3.92],8.054276954368966e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,1867,190,1.68 [1.44-1.97],8.179687350633803e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1864,187,2.12 [1.61-2.79],8.06047121204535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,1828,185,2.68 [2.06-3.48],1.4527020763950284e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,1841,187,1.87 [1.54-2.27],2.3391568465069415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,1840,187,3.07 [2.04-4.61],7.06670020323793e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,1788,185,1.80 [1.53-2.13],4.144304828739016e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,1867,190,3.06 [2.06-4.56],3.514947685698314e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,1850,189,2.64 [1.93-3.62],1.4681818508575052e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,1855,187,1.98 [1.56-2.50],1.1142527239711124e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,1782,184,2.40 [1.94-2.96],6.041587397758171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,1855,188,2.00 [1.55-2.58],8.424867910570038e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1855,188,3.03 [2.19-4.20],2.628373095863836e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,1834,187,3.02 [2.03-4.50],5.0421239603014004e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,1857,190,3.77 [2.52-5.64],1.0342253144382015e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1832,185,1.42 [1.26-1.60],7.0901772900767075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,1843,185,2.03 [1.72-2.41],1.301260798037574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,1869,190,1.70 [1.45-1.99],3.3192723134477536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,1845,187,2.03 [1.69-2.45],7.733121610808772e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,1850,189,1.53 [1.37-1.72],5.0720094896442095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,1863,190,2.35 [1.83-3.01],1.5744656110066318e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,1863,188,3.07 [2.21-4.27],2.0572494223440565e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,1791,181,2.39 [1.80-3.18],2.058862156479108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,1801,185,2.10 [1.66-2.65],8.008630351892414e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,1855,188,1.95 [1.63-2.33],1.933507977224921e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,1840,187,1.73 [1.48-2.01],1.898937469894067e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,1847,188,1.43 [1.27-1.62],1.572372517796002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,1848,187,1.78 [1.50-2.12],5.30006175517745e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,1840,188,1.81 [1.51-2.17],1.2883549092976128e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,1855,187,2.00 [1.56-2.56],4.7062187595660374e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1832,185,3.33 [2.35-4.72],1.578137547970129e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1864,187,2.23 [1.76-2.82],3.2502609114471985e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1855,187,2.15 [1.63-2.83],4.604269363285465e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1845,187,2.84 [2.14-3.77],3.822751805550757e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1855,188,2.99 [2.18-4.11],1.2148553316226188e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1862,187,2.10 [1.61-2.74],3.760265065068416e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1832,185,2.16 [1.67-2.78],3.376609914046825e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1853,187,3.14 [2.08-4.74],5.517835899524077e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,1860,187,0.57 [0.47-0.70],3.882764437113211e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1852,187,2.09 [1.65-2.65],1.2590465583818332e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,1761,176,2.08 [1.67-2.58],3.7885826625352846e-11
